Evidence map›Paper›PMID 37032646›Full record

ArticleEpigenetics2023

Nanopore sequencing reveals methylation changes associated with obesity in circulating cell-free DNA from Göttingen Minipigs.

Markus Hodal Drag, Karina Poulsdóttir Debes, Clara Sandkamm Franck, Mette Flethøj, Mille Kronborg Lyhne, Jacob Eifer Møller, Trine Pagh Ludvigsen, Thomas Jespersen, Lisbeth Høier Olsen, Tuomas O Kilpeläinen

Open access · diamondAbstract read
In one paragraph

Article in Epigenetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Circulating Cell-Free DNA in Metabolic Diseases.Journal of the Endocrine Society · 2025
    Review
  7. Current Updates on the Understanding of the Role of DNA Methylation on Obesity.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Markus Hodal DragNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Karina Poulsdóttir DebesDepartment of Veterinary and Animal Sciences, University of Copenhagen, Copenhagen, Denmark.
Clara Sandkamm FranckNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Mette FlethøjResearch & Early Development, Novo Nordisk A/S, Måløv, Denmark.
Mille Kronborg LyhneDepartment of Veterinary and Animal Sciences, University of Copenhagen, Copenhagen, Denmark.
Jacob Eifer MøllerDepartment of Cardiology, Copenhagen University Hospital and Odense University Hospital, Odense, Denmark.
Trine Pagh LudvigsenResearch & Early Development, Novo Nordisk A/S, Måløv, Denmark.
Thomas JespersenDepartment of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
Lisbeth Høier OlsenDepartment of Veterinary and Animal Sciences, University of Copenhagen, Copenhagen, Denmark.
Tuomas O KilpeläinenNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-8349-3028
University of Copenhagen · DKNovo Nordisk (Denmark) · DKOdense University Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Profiling of circulating cell-free DNA (cfDNA) by tissue-specific base modifications, such as 5-methylcytosines (5mC), may enable the monitoring of ongoing pathophysiological processes. Nanopore sequencing allows genome-wide 5mC detection in cfDNA without bisulphite conversion. The aims of this study were: i) to find differentially methylated regions (DMRs) of cfDNA associated with obesity in Göttingen minipigs using Nanopore sequencing, ii) to validate a subset of the DMRs using methylation-specific PCR (MSP-PCR), and iii) to compare the cfDNA DMRs with those from whole blood genomic DNA (gDNA). Serum cfDNA and gDNA were obtained from 10 lean and 7 obese Göttingen Minipigs both with experimentally induced myocardial infarction and sequenced using Oxford Nanopore MinION. A total of 1,236 cfDNA DMRs (FDR<0.01) were associated with obesity. In silico analysis showed enrichment of the adipocytokine signalling, glucagon signalling, and cellular glucose homoeostasis pathways. A strong cfDNA DMR was discovered in

Indexed as

Cell-Free Nucleic AcidsDiabetes Mellitus, Type 2Nanopore SequencingAnimalsDNADNA MethylationHumansObesityRNA-Binding ProteinsSwineSwine, MiniatureCell-Free Nucleic AcidsDNAPPARGC1B protein, humanRNA-Binding ProteinsCell-free DNAdiagnosticsepigeneticsmethylationNanopore sequencingobesity

Identifiers

PMID37032646
PMCPMC10088973
OpenAlexW4363645539

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.